Please note this application is under active development. If you spot any errors or something isn't working, please contact us at evidence.service@wales.nhs.uk.

Smoking cessation interventions for pulmonary tuberculosis treatment outcomes

Jeyashree K et al (2016)

Cochrane Database of Systematic Reviews - 10.1002/14651858.CD011125.pub2.

Evidence Categories

  • Care setting: Healthcare Setting
  • Population group: Pre existing health condition
  • Intervention: Bupropian
  • Intervention: Multicomponent Interventions
  • Intervention: Behaviour Support
  • Intervention: Other Pharmacotherapies
  • Intervention: Nicotine Replacement Therapy
  • Intervention: Varenicline
  • Outcome: Smoking cessation

Type of Evidence

Systematic Review

Aims

To analyse the effect of tobacco smoking cessation interventions (SCIs) on the treatment outcomes of people with adult pulmonary TB.

Findings

There were no randomised controlled trials that met the eligibility criteria. A number of potentially eligible studies are underway, and the authors will assess them for inclusion in the next update of this review

Conclusions

There is a lack of high-quality evidence, i.e. RCTs, that tests the effectiveness of cessation interventions in improving TB treatmentoutcomes. There is a need for good-quality randomised controlled trials that assess the effect of SCIs on TB treatment outcomes in both the short and long term. Establishing such an evidence base would be an essential step towards the implementation of SCIs in TB control programmes worldwide.